Maria Sharapova removed from Women's Tennis RankingsSport October 24, 11:17
Former MP appointed advisor to Russian National Guard’s chiefRussian Politics & Diplomacy October 24, 11:01
Unmanned Federation spacecraft to be launched from Vostochny spaceport in 2021Science & Space October 24, 10:42
Developer shows first image of Russia's new Sarmat ballistic missileMilitary & Defense October 24, 10:15
Moody's revises outlook on Russia's banking system to ‘stable’Business & Economy October 24, 10:00
Russia and Belarus held joint airborne drills in BrestMilitary & Defense October 24, 8:16
District head: all people on board crashed helicopter in Transbaikal deadSociety & Culture October 24, 8:16
Kremlin ex-chief: Russia is ready to open new page in relations with US after electionsRussian Politics & Diplomacy October 24, 4:10
Russian inspectors to hold observation flight over TurkeyRussian Politics & Diplomacy October 24, 2:30
NOVOSIBIRSK, December 2. /TASS/. Experts of a research laboratory of Novosibirsk State University, who study problems of microbiology and methods of anti-virus therapy, are hoping to create a vaccine against Ebola-related diseases, Deputy rector of the Novosibirsk university in charge of scientific research Sergey Netesov told TASS on Tuesday.
"The university laboratory will not experiment with the Ebola virus itself; they are planning to create the vaccine, using the replica of Ebola's DNA genes, which is safe for the laboratory staff and its environment," Netesov said.
"The researchers are planning to implant the genes of the EBOLA virus into the structure of the adenovirus which causes virus-related diseases transmitted by air. The hoped result is getting a certain adenovirus culture which will be tested as anti-Ebola vaccine," Netesov said.
Problems of financing the research have been negotiated. It might take two-three years to develop the right virus culture, he added.
The research laboratory was created at Novosibirsk State University in spring 2014 on funds provided by the Russian government as grants for scientific research.